Tong, Bingqi
Luo, Mai
Xie, Yi
Spradlin, Jessica N.
Tallarico, John A.
McKenna, Jeffrey M.
Schirle, Markus
Maimone, Thomas J.
Nomura, Daniel K.
Funding for this research was provided by:
National Institutes of Health (R01CA240981, F31CA239327)
Novartis Institutes for BioMedical Research
Mark Foundation For Cancer Research (ASPIRE Award)
Article History
Received: 19 July 2020
Accepted: 27 August 2020
First Online: 23 September 2020
Competing interests
: J.A.T, J.M.M, M.S. are employees of Novartis Institutes for BioMedical Research. This study was funded by the Novartis Institutes for BioMedical Research and the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. D.K.N. is a co-founder, shareholder, and adviser for Artris Therapeutic and Frontier Medicines. T.J.M., B.T., Y.X., M.L., and J.N.S. declare no competing interests.